Melanie Zenger

764 total citations
29 papers, 335 citations indexed

About

Melanie Zenger is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Melanie Zenger has authored 29 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Melanie Zenger's work include Acute Myeloid Leukemia Research (20 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). Melanie Zenger is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). Melanie Zenger collaborates with scholars based in Germany, Austria and Japan. Melanie Zenger's co-authors include Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Susanne Schnittger, Ulrike Bacher, Tamara Alpermann, Alexander Kohlmann, Anna Stengel, Karolína Perglerová and Dietrich W. Beelen and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Melanie Zenger

28 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie Zenger Germany 9 247 120 103 80 68 29 335
Camino Estivill Spain 11 195 0.8× 78 0.7× 79 0.8× 174 2.2× 59 0.9× 21 328
Cristina Ariola Italy 10 180 0.7× 81 0.7× 89 0.9× 72 0.9× 40 0.6× 15 315
C. Troff Germany 7 224 0.9× 91 0.8× 78 0.8× 77 1.0× 51 0.8× 13 301
Karolína Perglerová Germany 6 194 0.8× 91 0.8× 63 0.6× 109 1.4× 35 0.5× 15 256
Lucia Anna De Novi Italy 8 145 0.6× 98 0.8× 134 1.3× 42 0.5× 113 1.7× 14 295
Heinz Kirchen Germany 7 292 1.2× 195 1.6× 104 1.0× 149 1.9× 139 2.0× 10 480
Marzia Cavalli Italy 7 133 0.5× 94 0.8× 127 1.2× 44 0.6× 111 1.6× 16 286
Matthew Smith United Kingdom 4 222 0.9× 90 0.8× 52 0.5× 162 2.0× 28 0.4× 8 306
Ying‐Jung Huang Taiwan 9 172 0.7× 70 0.6× 61 0.6× 134 1.7× 21 0.3× 21 243

Countries citing papers authored by Melanie Zenger

Since Specialization
Citations

This map shows the geographic impact of Melanie Zenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Zenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Zenger more than expected).

Fields of papers citing papers by Melanie Zenger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Zenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Zenger. The network helps show where Melanie Zenger may publish in the future.

Co-authorship network of co-authors of Melanie Zenger

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Zenger. A scholar is included among the top collaborators of Melanie Zenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Zenger. Melanie Zenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haferlach, Claudia, Wencke Walter, Melanie Zenger, et al.. (2020). Artificial Intelligence Substantially Supports Chromosome Banding Analysis Maintaining Its Strengths in Hematologic Diagnostics Even in the Era of Newer Technologies. Blood. 136(Supplement 1). 47–48. 10 indexed citations
2.
Zenger, Melanie, Manja Meggendorfer, Stephan Hütter, et al.. (2020). Analysis of Mechanisms of Blast Crisis in Chronic Myeloid Leukemia By Whole Genome Sequencing. Blood. 136(Supplement 1). 19–19. 4 indexed citations
3.
Vetro, Calogero, Torsten Haferlach, Sabine Jeromin, et al.. (2018). Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses. British Journal of Haematology. 183(1). 47–59. 3 indexed citations
5.
Stengel, Anna, Wolfgang Kern, Melanie Zenger, et al.. (2015). Genetic characterization of T‐PLL reveals two major biologic subgroups and JAK3 mutations as prognostic marker. Genes Chromosomes and Cancer. 55(1). 82–94. 54 indexed citations
6.
Haferlach, Claudia, Sabine Jeromin, Niroshan Nadarajah, et al.. (2015). Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increased ERG expression in acute myeloid leukemia. Genes Chromosomes and Cancer. 55(2). 148–157. 10 indexed citations
8.
Schnittger, Susanne, et al.. (2014). Amplification of EVI1 on cytogenetically cryptic double minutes as new mechanism for increased expression of EVI1. Cancer Genetics. 207(3). 103–108. 8 indexed citations
10.
Roller, Andreas, Alexander Kohlmann, Melanie Zenger, et al.. (2013). Gene Amplifications In 84 Patients With Acute Myeloid Leukemia and 31 Patients With Myelodysplastic Syndrome Investigated By Array CGH. Blood. 122(21). 3724–3724. 1 indexed citations
11.
Zenger, Melanie, Susanne Schnittger, Sandra Weißmann, et al.. (2013). Acute Lymphoblastic Leukemia (ALL) With Low-Hypodiploid/Near-Triploid Karyotype Is a Specific Clinical Entity Characterized By a High TP53 Mutation Frequency. Blood. 122(21). 615–615. 2 indexed citations
13.
Haferlach, Claudia, Ulrike Bacher, Vera Grossmann, et al.. (2012). Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases. Genes Chromosomes and Cancer. 51(12). 1079–1085. 26 indexed citations
14.
Haferlach, Claudia, Melanie Zenger, Vera Großmann, et al.. (2012). The Impact of Homozygosity and Size of the 13q Deletion in Patients with CLL. Blood. 120(21). 3892–3892. 1 indexed citations
15.
Haferlach, Claudia, Vera Großmann, Melanie Zenger, et al.. (2012). RUNX1 Deletions Are a Novel Mechanism of Loss of Function in AML and Are Associated with Adverse Cytogenetics.. Blood. 120(21). 2517–2517. 3 indexed citations
16.
Bacher, Ulrike, Torsten Haferlach, Tamara Alpermann, et al.. (2011). Subclones with the t(9;22)/BCR‐ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations. British Journal of Haematology. 152(6). 713–720. 41 indexed citations
17.
Haferlach, Claudia, Ulrike Bacher, Susanne Schnittger, et al.. (2011). ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events. Genes Chromosomes and Cancer. 51(4). 328–337. 36 indexed citations
19.
Haferlach, Claudia, Vera Grossmann, Melanie Zenger, et al.. (2011). Gene Amplifications Are Rare Events in AML and MDS and Are Associated with Complex Karyotype, TP53 Deletions and Very Poor Survival. Blood. 118(21). 2524–2524. 3 indexed citations
20.
Bacher, Ulrike, Torsten Haferlach, Tamara Alpermann, et al.. (2010). Comparison of Cytogenetic Clonal Evolution Patterns following Allogeneic Hematopoietic Transplantation versus Conventional Treatment in Patients at Relapse of AML. Biology of Blood and Marrow Transplantation. 16(12). 1649–1657. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026